Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on May 20, 2025
INVO Fertility Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 20, 2025
SARASOTA, Fla., May 20, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …
Tactile Medical to Present at Upcoming Investor Conferences in June
GlobeNewswire
·
May 20, 2025
MINNEAPOLIS, May 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will be …
Soleno Therapeutics Announces Data Presentation Showing that Resumption of Treatment with VYKAT(TM) XR after a Randomized Withdrawal Period was Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in Participants with…
GlobeNewswire
·
May 20, 2025
REDWOOD CITY, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced data presented from its clinical development …
HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of Werewolf Therapeutics' investigational novel conditionally activated IL-2 pro-drug WTX-124
GlobeNewswire
·
May 20, 2025
There are nearly 40,000 U.S. cases of cutaneous squamous cell carcinoma each year that advance to stages that are difficult to treat and life-threatening Skin Cancer Awareness Month in May shines a spotlight on the growing burden of advanced skin cancers …
Avalyn Showcases Clinical Data Across Multiple Pulmonary Fibrosis Programs at ATS 2025
GlobeNewswire
·
May 20, 2025
Topline results for AP02 (inhaled nintedanib) confirmed safety and tolerability with limited systemic exposure and substantially improved lung exposure compared to oral nintedanib AP01 (inhaled pirfenidone) treatment demonstrated long-term antifibrotic …
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody
GlobeNewswire
·
May 20, 2025
Pharmacokinetic and safety data from healthy volunteers anticipated around YE 2025 On track to initiate a Phase 2 study in 1H 2026 ORKA-002 preclinical data demonstrate the potential for dosing two to three times per year in psoriasis, a significant …
Healthcare Saas Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034
EIN Presswire
·
May 20, 2025
The Business Research Company's Healthcare Saas Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 20, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores …
Global Poultry Disinfectant Market To Reach $7.78 Billion By 2029 With A Growth Rate Of 11.1%
EIN Presswire
·
May 20, 2025
The Business Research Company’s Poultry Disinfectant Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 20, 2025 /EINPresswire.com/ -- Would you believe that the poultry disinfectant …
Global Healthcare Consulting Services Market Forecast: Key Growth Drivers, Trends, and Opportunities from 2025 to 2034
EIN Presswire
·
May 20, 2025
The Business Research Company's Healthcare Consulting Services Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 20, 2025 /EINPresswire.com/ -- In essence, the healthcare …
Exploring The Projections Of Small Molecule Active Pharmaceutical Ingredient Global Market Report 2025
EIN Presswire
·
May 20, 2025
The Business Research Company’s Small Molecule Active Pharmaceutical Ingredient Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 20, 2025 /EINPresswire.com/ -- The global small …
Pharmaceutical Drugs Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034
EIN Presswire
·
May 20, 2025
The Business Research Company’s Pharmaceutical Drugs Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 20, 2025 /EINPresswire.com/ -- The pharmaceutical drugs global market report 2025 …
Global Menopause Treatment Market Forecast To Reach $24.28 Billion By 2029 With 6.5% Annual Growth
EIN Presswire
·
May 20, 2025
The Business Research Company's Global Menopause Treatment Market Forecast To Reach $24.28 Billion By 2029 With 6.5% Annual Growth LONDON, GREATER LONDON, UNITED KINGDOM, May 20, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …
Global HER2 Inhibitors Market Growth: Projected to Reach $13.61 Billion by 2029 with an Impressive 9.0% CAGR
EIN Presswire
·
May 20, 2025
The Business Research Company's HER2 Inhibitors Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 20, 2025 /EINPresswire.com/ -- The HER2 Inhibitors Global Market Report 2025 …
Prescription Dermatological Drugs Global Market Set to Soar to $40.38 Billion by 2025
EIN Presswire
·
May 20, 2025
The Business Research Company’s Prescription Dermatological Drugs Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 20, 2025 /EINPresswire.com/ -- The prescription dermatological drugs …
Alameda Health System expands stroke care with Wilma Chan Highland Hospital Campus’ new certification
GlobeNewswire
·
May 20, 2025
OAKLAND, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Alameda Health System (AHS) patients experiencing the sudden and frightening symptoms of a stroke will now receive faster and more-integrated care, thanks to the Wilma Chan Highland Hospital Campus’ (WCHHC) …
Moderate to Severe Atopic Dermatitis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight
GlobeNewswire
·
May 20, 2025
New York, USA, May 20, 2025 (GLOBE NEWSWIRE) -- Moderate to Severe Atopic Dermatitis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight The moderate to severe atopic dermatitis market is experiencing strong growth driven by rising …
America's Blood Centers Releases New Report Showing the Critical Role of Community Blood Centers in Expanding Prehospital Blood Programs
GlobeNewswire
·
May 20, 2025
Washington, DC, May 20, 2025 (GLOBE NEWSWIRE) -- America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood supply, today released its latest report, "A Vital Resource …
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
GlobeNewswire
·
May 20, 2025
ZURICH, May 20, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), announced today the appointment of …
Santheras Aktionäre stimmen an der heutigen Generalversammlung allen Anträgen des Verwaltungsrats zu
GlobeNewswire
·
May 20, 2025
Pratteln, Schweiz, 20. Mai 2025 - Santhera Pharmaceuticals (SIX: SANN) gibt heute bekannt, dass die Aktionäre an der heutigen Generalversammlung (GV) in Pratteln, Schweiz, allen Anträgen des Verwaltungsrates mit grosser Mehrheit zugestimmt haben. Die …
Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting
GlobeNewswire
·
May 20, 2025
Pratteln, Switzerland, May 20, 2025 – Santhera Pharmaceuticals (SIX: SANN) today announces that its shareholders approved all motions by the Board of Directors at the Annual General Meeting (AGM) held today in Pratteln, Switzerland, with a large majority. …